Sun Pharma Advanced Research Company Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹8.45 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7.51 per cent from ₹7.86 crore. This corresponds to a year-on-year *(YoY) decline of 43.33 per cent.
Operating Profit
Operating Profit stands at ₹-69.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 4.99 per cent from ₹-65.72 crore. This corresponds to a year-on-year *(YoY) growth of 6.36 per cent.
PBDT
PBDT stands at ₹-77.78 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 6.21 per cent from ₹-73.23 crore. This corresponds to a year-on-year *(YoY) decline of 1.94 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-80.35 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 6.02 per cent from ₹-75.79 crore. This corresponds to a year-on-year *(YoY) decline of 1.15 per cent.
Net Profit
Net Profit stands at ₹-80.42 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 6.03 per cent from ₹-75.85 crore. This represents a 1.14 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Sun Pharma Advanced Research Company Ltd News
Sun Pharma Advanced Research Company Ltd Earnings
- YOY
- QOQ
Sun Pharma Advanced Research Company Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Sun Pharma Advanced Research Company Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Sun Pharma Advanced Research Company Ltd Financial Reports
Sun Pharma Advanced Research Company Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| SPARC | -0.40% | 22.92% | 20.89% | 27.57% | 29.29% | 15.85% |
| Aarti Pharma | -1.84% | -2.49% | 8.50% | 5.82% | -0.90% | -5.75% |
| FDC | 0.38% | 3.58% | 8.45% | -1.56% | -6.27% | -12.18% |
| Supriya Lifesci. | 0.01% | 2.11% | 11.15% | 3.36% | -7.03% | 6.95% |
| Innova Captab | -0.69% | -0.09% | 26.01% | 25.82% | 22.73% | -6.90% |
| Advanced Enzyme | 13.08% | 13.15% | 35.09% | 32.15% | 22.05% | 36.30% |
| Senores Pharma. | 0.82% | 10.53% | 16.50% | 21.39% | 25.23% | 91.12% |
Company Info
Company Information
Non Executive Director : T Rajamannar
Independent Director : Bhavna Doshi
Independent Director : Ferzaan Engineer
Independent Director : Robert Spiegel
Chairman (Non-Executive) : Dilip S Shanghvi
Company Sec. & Compli. Officer : Kajal Damania.
Non Executive Director : Vidhi Shanghvi
Independent Director : Rekha Gopal Warriar
Independent Director : Venkateswarlu Jasti